Clinical Trial Update: Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing HTD1801 (berberine ursodeoxycholate) to dapagliflozin in patients with Type 2 diabetes inadequately controlled on metformin has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• HTD1801

Snippet

Sponsor: HighTide Biopharma Pty Ltd | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Status: COMPLETED